Oncology

Bicara Therapeutics

Clinical-stage company developing unique bifunctional antibodies targeting tumors and modulating their microenvironment for treating cancer.

Red Tree Participation
Co-investor in seed round, co-led Series B

Red Tree Board Member

Heath Lukatch, Ph.D.

Total Addressable Market
Red Tree Board Member(s)

Red Tree Board Member

Heath Lukatch, Ph.D.

Red Tree Participation
Co-investor in seed round, co-led Series B

Bicara Therapeutics

Oncology
Total Addressable Market
Red Tree Board Member(s)

Red Tree Board Member

Heath Lukatch, Ph.D.

Red Tree Participation
Co-investor in seed round, co-led Series B